{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:29:30Z","timestamp":1794745770490,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Due to the late manifestation of structural symptoms and symptomatic overlap, neurodegenerative diseases such as Parkinson\u2019s Disease (PD) and Alzheimer\u2019s Disease (AD) remain difficult to diagnose accurately. In order to categorize AD and PD in comparison to Healthy Controls (HC), this study suggests a multimodal classification framework that combines genetic Single Nucleotide Polymorphism (SNP) data, structural Magnetic Resonance Imaging (MRI), and functional Electroencephalography (EEG). To improve the model\u2019s accuracy and interpretability, the method makes use of an uncertainty estimate module and a novel cross-modality attention mechanism. The framework strives for diagnosis, concentrating on detecting Parkinson\u2019s disease (PD) and Alzheimer\u2019s disease (AD) in individuals exhibiting modest motor symptoms or early cognitive impairments, which are indicative of the prodromal stage of both conditions. A dataset of 2,500 MRI images, 1,500 EEG recordings, and SNP data for 1,000 subjects drawn from OpenNeuro, PPMI, and the UK Biobank was utilized in extensive analyses. The developed model was contrasted with recent unimodal and multimodal techniques. Our findings exhibit statistically significant increases of 6\u201312% compared to similar methods, with 95.6% average classification accuracy on AD and 94.8% on PD. The importance of the attention mechanism and both modalities to overall performance is quantified using ablation studies. Quantification of uncertainty also improves interpretability for possible clinical use. These results demonstrate the proper neurodegenerative disease diagnosis when explainable AI elements are paired with stable multimodal fusion.<\/jats:p>","DOI":"10.1038\/s41598-025-32274-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:19:20Z","timestamp":1768565960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An attention-augmented multimodal classification of alzheimer\u2019s disease and parkinson\u2019s disease vs healthy controls using MRI, EEG, and SNP data"],"prefix":"10.1038","volume":"16","author":[{"given":"Basu Dev","family":"Shivahare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Rajadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Kansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar","family":"Mathivanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"S.K.B","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"13","key":"32274_CR1","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.3390\/jcm11133704","volume":"11","author":"M Szandruk-Bender","year":"2022","unstructured":"Szandruk-Bender, M., Wiatrak, B. & Szel\u0105g, A. The risk of developing Alzheimer\u2019s disease and Parkinson\u2019s disease in patients with inflammatory bowel disease: a meta-analysis. J. Clin. Med. 11(13), 3704 (2022).","journal-title":"J. Clin. Med."},{"issue":"1","key":"32274_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade, P. et al. Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng. Trans. Med. 8(1), e10367 (2023).","journal-title":"Bioeng. Trans. Med."},{"issue":"1","key":"32274_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JPD-202323","volume":"11","author":"Y Compta","year":"2021","unstructured":"Compta, Y. & Revesz, T. Neuropathological and biomarker findings in Parkinson\u2019s disease and Alzheimer\u2019s disease: from protein aggregates to synaptic dysfunction. J. Parkinsons Dis. 11(1), 107\u2013121 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"32274_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijbiomac.2021.08.197","volume":"190","author":"P Salahuddin","year":"2021","unstructured":"Salahuddin, P. et al. The role of amyloids in Alzheimer\u2019s and Parkinson\u2019s diseases. Int. J. Biol. Macromol. 190, 44\u201355 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"32274_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fnins.2020.00157","volume":"14","author":"YJ Song","year":"2020","unstructured":"Song, Y. J. et al. The effect of estrogen replacement therapy on Alzheimer\u2019s disease and Parkinson\u2019s disease in postmenopausal women: a meta-analysis. Front. Neurosci. 14, 157 (2020).","journal-title":"Front. Neurosci."},{"key":"32274_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-12-819973-2.00030-7","volume":"182","author":"IM Walker","year":"2021","unstructured":"Walker, I. M., Fullard, M. E., Morley, J. F. & Duda, J. E. Olfaction as an early marker of Parkinson\u2019s disease and Alzheimer\u2019s disease. Handb. Clin. Neurol. 182, 317\u2013329 (2021).","journal-title":"Handb. Clin. Neurol."},{"key":"32274_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112343","volume":"145","author":"Z Hang","year":"2022","unstructured":"Hang, Z. et al. Composition of intestinal flora affects the risk relationship between Alzheimer\u2019s disease\/Parkinson\u2019s disease and cancer. Biomed. Pharmacother. 145, 112343 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"32274_CR8","doi-asserted-by":"crossref","unstructured":"Irwin, D. J., Fedler, J., Coffey, C. S., Caspell\u2010Garcia, C., Kang, J. H., Simuni, T., ... & Parkinson\u2019s Progression Marker Initiative.  Evolution of Alzheimer\u2019s disease cerebrospinal fluid biomarkers in early Parkinson\u2019s disease. Annals of neurology, 88(3), 574\u2013587. (2020)","DOI":"10.1002\/ana.25811"},{"key":"32274_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.730036","volume":"14","author":"S Xiang","year":"2022","unstructured":"Xiang, S. et al. Efficacy and safety of probiotics for the treatment of Alzheimer\u2019s disease, mild cognitive impairment, and Parkinson\u2019s disease: a systematic review and meta-analysis. Front. Aging Neurosci. 14, 730036 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"32274_CR10","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1007\/s11064-022-03667-0","volume":"47","author":"MR Khezri","year":"2022","unstructured":"Khezri, M. R. & Ghasemnejad-Berenji, M. Icariin: a potential neuroprotective agent in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neurochem. Res. 47(10), 2954\u20132962 (2022).","journal-title":"Neurochem. Res."},{"key":"32274_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.691512","volume":"13","author":"M Zhang","year":"2021","unstructured":"Zhang, M. & Bian, Z. The emerging role of circular RNAs in Alzheimer\u2019s disease and Parkinson\u2019s disease. Front. Aging Neurosci. 13, 691512 (2021).","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"32274_CR12","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/ijms22094958","volume":"22","author":"F Paolini Paoletti","year":"2021","unstructured":"Paolini Paoletti, F., Simoni, S., Parnetti, L. & Gaetani, L. The contribution of small vessel disease to neurodegeneration: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis. Int. J. Mol. Sci. 22(9), 4958 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32274_CR13","doi-asserted-by":"publisher","first-page":"111821","DOI":"10.1016\/j.mad.2023.111821","volume":"212","author":"A Nicoletti","year":"2023","unstructured":"Nicoletti, A. et al. Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Amyotrophic Lateral Sclerosis: A narrative review. Mechan. Ageing Dev. 212, 111821 (2023).","journal-title":"Mechan. Ageing Dev."},{"key":"32274_CR14","doi-asserted-by":"crossref","unstructured":"Sangeetha, S. K. B., Immanuel, R. R., Mathivanan, S. K., Cho, J., & Easwaramoorthy, S. V. (2024). An Empirical Analysis of Multimodal Affective Computing Approaches for Advancing Emotional Intelligence in Artificial Intelligence for Healthcare. IEEE Access.","DOI":"10.1109\/ACCESS.2024.3444494"},{"key":"32274_CR15","first-page":"1","volume":"13","author":"T Katayama","year":"2021","unstructured":"Katayama, T., Sawada, J., Takahashi, K., Yahara, O. & Hasebe, N. Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer\u2019s disease, Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer\u2019s Res. Therapy 13, 1\u201310 (2021).","journal-title":"Alzheimer\u2019s Res. Therapy"},{"issue":"9","key":"32274_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004092","volume":"19","author":"J Sun","year":"2022","unstructured":"Sun, J. et al. Hospital-treated infections in early-and mid-life and risk of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: a nationwide nested case-control study in Sweden. PLoS Medicine. 19(9), e1004092 (2022).","journal-title":"PLoS Medicine."},{"key":"32274_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.786337","volume":"13","author":"MJ Kwon","year":"2021","unstructured":"Kwon, M. J. et al. The occurrence of Alzheimer\u2019s disease and Parkinson\u2019s disease in individuals with osteoporosis: A longitudinal follow-up study using a national health screening database in Korea. Front. Aging Neurosci. 13, 786337 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"32274_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2020.102078","volume":"83","author":"I Bisht","year":"2020","unstructured":"Bisht, I., Ambasta, R. K. & Kumar, P. An integrated approach to unravel a putative crosstalk network in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neuropeptides 83, 102078 (2020).","journal-title":"Neuropeptides"},{"issue":"3","key":"32274_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/arclin\/acz082","volume":"36","author":"I Kozlova","year":"2021","unstructured":"Kozlova, I., Parra, M. A., Titova, N., Gantman, M. & Sala, S. D. Alzheimer\u2019s disease and Parkinson dementia distinguished by cognitive marker. Arch. Clin. Neuropsychol. 36(3), 307\u2013315 (2021).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"32274_CR20","doi-asserted-by":"publisher","first-page":"120166","DOI":"10.1016\/j.jns.2022.120166","volume":"434","author":"RJ Solch","year":"2022","unstructured":"Solch, R. J. et al. Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: A systematic review. J. Neurol. Sci 434, 120166 (2022).","journal-title":"J. Neurol. Sci"},{"issue":"8","key":"32274_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","volume":"80","author":"E d\u2019Angremont","year":"2023","unstructured":"d\u2019Angremont, E., Begemann, M. J., Van Laar, T. & Sommer, I. E. Cholinesterase inhibitors for treatment of psychotic symptoms in Alzheimer disease and Parkinson disease: a meta-analysis. JAMA Neurol. 80(8), 813\u2013823 (2023).","journal-title":"JAMA Neurol."},{"key":"32274_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.sasc.2023.200068","volume":"6","author":"SKB Sangeetha","year":"2024","unstructured":"Sangeetha, S. K. B. et al. An enhanced multimodal fusion deep learning neural network for lung cancer classification. Syst. Soft Comput. 6, 200068 (2024).","journal-title":"Syst. Soft Comput."},{"key":"32274_CR23","first-page":"15125","volume":"34","author":"S Lu","year":"2021","unstructured":"Lu, S., Li, J., Tan, J., Yang, S. & Liu, J. Tnasp: A transformer-based nas predictor with a self-evolution framework. Adv. Neural. Inf. Process. Syst. 34, 15125\u201315137 (2021).","journal-title":"Adv. Neural. Inf. Process. Syst."},{"key":"32274_CR24","doi-asserted-by":"crossref","unstructured":"Raghu, S. T. P., Williams, H. E., & Scheme, E. (2025). Efficient Multi-Positioned Training for Regression-Based Myoelectric Control: Exploring Transformer Models with Transfer Learning. In 2025 International Conference On Rehabilitation Robotics (ICORR) (1597\u20131603). IEEE.","DOI":"10.1109\/ICORR66766.2025.11063067"},{"key":"32274_CR25","first-page":"1","volume":"61","author":"L Shen","year":"2023","unstructured":"Shen, L., Su, H., Li, Z., Jia, C. & Yang, R. Self-attention-based Transformer for nonlinear maneuvering target tracking. IEEE Trans. Geosci. Remote Sens. 61, 1\u201313 (2023).","journal-title":"IEEE Trans. Geosci. Remote Sens."},{"key":"32274_CR26","doi-asserted-by":"crossref","unstructured":"Chen, Q., & Hong, Y. (2024). SMART: Self-Weighted Multimodal Fusion for Diagnostics of Neurodegenerative Disorders. In Proceedings of the 32nd ACM International Conference on Multimedia (4426\u20134435).","DOI":"10.1145\/3664647.3681140"},{"issue":"1","key":"32274_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13755-023-00231-0","volume":"11","author":"G Huang","year":"2023","unstructured":"Huang, G., Li, R., Bai, Q. & Alty, J. Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review. Health Inf. Sci. Syst. 11(1), 32 (2023).","journal-title":"Health Inf. Sci. Syst."},{"issue":"1","key":"32274_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5755\/j01.itc.53.1.34718","volume":"53","author":"CMT Karthigeyan","year":"2024","unstructured":"Karthigeyan, C. M. T. & Rani, C. Optimizing Parkinson\u2019s disease diagnosis with multimodal data fusion techniques. Inf. Technol. Control 53(1), 262\u2013279 (2024).","journal-title":"Inf. Technol. Control"},{"issue":"2","key":"32274_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/MMUL.2022.3156471","volume":"29","author":"S Dwivedi","year":"2022","unstructured":"Dwivedi, S., Goel, T., Tanveer, M., Murugan, R. & Sharma, R. Multimodal fusion-based deep learning network for effective diagnosis of Alzheimer\u2019s disease. IEEE Multimedia 29(2), 45\u201355 (2022).","journal-title":"IEEE Multimedia"},{"key":"32274_CR30","doi-asserted-by":"crossref","unstructured":"Zhao, A., Li, J., Dong, J., Qi, L., Zhang, Q., Li, N., ... & Zhou, H. Multimodal gait recognition for neurodegenerative diseases. IEEE transactions on cybernetics, 52(9), 9439\u20139453. (2021)","DOI":"10.1109\/TCYB.2021.3056104"},{"issue":"1","key":"32274_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1109\/JBHI.2024.3472462","volume":"29","author":"DP Dao","year":"2024","unstructured":"Dao, D. P., Yang, H. J., Kim, J., Ho, N. H. & Initiative, A. D. N. Longitudinal alzheimer\u2019s disease progression prediction with modality uncertainty and optimization of information flow. IEEE J. Biomed. Health Inform. 29(1), 259\u2013272 (2024).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"32274_CR32","doi-asserted-by":"crossref","unstructured":"Dhivyaa, S. P., Dao, D. P., Yang, H. J., & Kim, J. (2024, December). Adaptive Cross-Modal Representation Learning for Heterogeneous Data Types in Alzheimer Disease Progression Prediction with Missing Time Point and Modalities. In International Conference on Pattern Recognition (267\u2013282). Cham: Springer Nature Switzerland.","DOI":"10.1007\/978-3-031-78198-8_18"},{"issue":"10","key":"32274_CR33","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1109\/TMI.2019.2913158","volume":"38","author":"T Zhou","year":"2019","unstructured":"Zhou, T., Liu, M., Thung, K. H. & Shen, D. Latent representation learning for Alzheimer\u2019s disease diagnosis with incomplete multi-modality neuroimaging and genetic data. IEEE Trans. Med. Imaging 38(10), 2411\u20132422 (2019).","journal-title":"IEEE Trans. Med. Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32274-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:08:09Z","timestamp":1769213289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32274"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32274-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2422"}}